Advertisement
Heart, Lung and Circulation
Advanced searchSave search
Letter to the Editor| Volume 31, ISSUE 2, e17-e19, February 2022

Changing Practice: Procedural Volume of Transcatheter Aortic Valve Implantation by Age and Funding in New South Wales, 2002–2018

Published:October 13, 2021DOI:https://doi.org/10.1016/j.hlc.2021.09.010
Changing Practice: Procedural Volume of Transcatheter Aortic Valve Implantation by Age and Funding in New South Wales, 2002–2018
Previous ArticleThe Australian National Standards of Care for Childhood-Onset Heart Disease (CoHD)
Next ArticleHigh Prevalence of Lipid-Related Residual Risk in ACS Patients
      Transcatheter aortic valve replacement (TAVI) was first subsidised by Medicare in 2017 for inoperable patients or those too high-risk for surgical aortic valve replacement (SAVR). Internationally, TAVI guidelines have expanded to include intermediate-risk patients, despite limited long-term trial evidence. Lee et al. [
      • Lee A.H.
      • Ng A.C.C.
      • Yong A.S.C.
      • Hyun K.
      • Brieger D.
      • Kritharides L.
      • et al.
      Outcomes of 1,098 patients following transcatheter aortic valve implantation: a statewide population-linkage cohort study.
      Heart Lung Circ. 2021; 30: 1213-1220
      ] recently reported that the number of TAVI in New South Wales (NSW) increased 10-fold between 2013 and 2017.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Lee A.H.
        • Ng A.C.C.
        • Yong A.S.C.
        • Hyun K.
        • Brieger D.
        • Kritharides L.
        • et al.
        Outcomes of 1,098 patients following transcatheter aortic valve implantation: a statewide population-linkage cohort study.
        Heart Lung Circ. 2021; 30: 1213-1220
        View in Article
        • Sedrakyan A.
        • Dhruva S.S.
        • Sun T.
        • Mao J.
        • Gaudino M.F.
        • Redberg R.F.
        Trends in use of transcatheter aortic valve replacement by age.
        JAMA. 2018; 320: 598-600
        View in Article
        • Ali N.
        • Faour A.
        • Rawlins J.
        • Dawkins S.
        • Appleby C.E.
        • MacCarthy P
        • et al.
        ‘Valve for Life’: tackling the deficit in transcatheter treatment of heart valve disease in the UK.
        Open Heart. 2021; 8: e001547
        View in Article
        • NSW Treasury
        Outcomes Statement 2021-22.
        NSW Treasury, 2021 (Budget Paper No. 2. Sydney)
        https://www.budget.nsw.gov.au/sites/default/files/2021-06/Budget%20Paper%20No.%202%20-%20Outcomes%20Statement%20Budget%202021-22_0.pdf
        View in Article

      Article info

      Publication history

      Published online: October 13, 2021
      Accepted: September 9, 2021
      Received: September 2, 2021

      Identification

      DOI: https://doi.org/10.1016/j.hlc.2021.09.010

      Copyright

      © 2021 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      Linked Article

      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX